Wang X, Feuerstein G Z, Gu J L, Lysko P G, Yue T L
Department of Cardiovascular Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA.
Atherosclerosis. 1995 May;115(1):89-98. doi: 10.1016/0021-9150(94)05503-b.
Increased expression of cell adhesion molecules is an important pathological event during the development of atherosclerosis. The smooth muscle cell (SMC) is one of the cell types present in the atherosclerotic lesion. To evaluate the regulation of adhesion molecules in human vascular SMCs and its possible role, we studied the expression of adhesion molecules in SMCs stimulated with interleukin 1-beta (IL-1 beta), a pleiotropic cytokine that is involved in the pathological development of vascular diseases including atherosclerosis and restenosis. Our data demonstrated that IL-1 beta markedly induced the adhesiveness of human vascular SMCs for monocytes and neutrophils in a concentration (10 pM - 10 nM)- and time (0.5-24 h)-dependent manner. The maximal induced adhesion by IL-1 beta (1 nM) was reached at 4 h, with 4.6-fold and 3.3-fold for monocytes and neutrophils, respectively. This induction was dose-dependently inhibited by the IL-1 receptor antagonist (IL-1 ra). The IL-1 beta-induced expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and E-selectin 1 (ELAM-1) on SMCs was examined by reverse transcription/polymerase chain reaction (RT/PCR). Unstimulated, serum-deprived SMCs expressed a low or undetectable level of mRNA for these adhesion molecules. The expression of ICAM-1 and VCAM-1 but not ELAM-1 mRNA was significantly induced with IL-1 beta in a concentration (1 fM - 1 nM)- and time (0.5 - 24 h)-dependent manner. The maximal increase in ICAM-1 and VCAM-1 mRNAs was reached at 4 h after IL-1 beta stimulation. The IL-1 beta-induced adhesion of SMCs for monocytes was partially inhibited by monoclonal anti-human ICAM-1 and anti-human VCAM-1 antibody, but not by anti-human ELAM-1 antibody. Pretreatment of monocytes with anti-human integrin beta 2 antibody significantly reduced the adhesion of monocytes to IL-1 beta-stimulated SMCs. These results suggest that IL-1 beta is a potent inducer for ICAM-1 and VCAM-1 expression in human vascular SMC, and could play a role in the pathogenesis of atherosclerosis by recruitment and retention of inflammatory cells such as monocytes and neutrophils in the lesions.
细胞黏附分子表达增加是动脉粥样硬化发展过程中的一个重要病理事件。平滑肌细胞(SMC)是动脉粥样硬化病变中存在的细胞类型之一。为了评估人血管平滑肌细胞中黏附分子的调控及其可能的作用,我们研究了白细胞介素1-β(IL-1β)刺激下平滑肌细胞中黏附分子的表达,IL-1β是一种多效性细胞因子,参与包括动脉粥样硬化和再狭窄在内的血管疾病的病理发展。我们的数据表明,IL-1β以浓度(10 pM - 10 nM)和时间(0.5 - 24小时)依赖性方式显著诱导人血管平滑肌细胞对单核细胞和中性粒细胞的黏附性。IL-1β(1 nM)诱导的最大黏附在4小时时达到,单核细胞和中性粒细胞分别增加4.6倍和3.3倍。这种诱导被IL-1受体拮抗剂(IL-1 ra)剂量依赖性抑制。通过逆转录/聚合酶链反应(RT/PCR)检测IL-1β诱导的平滑肌细胞上细胞间黏附分子1(ICAM-1)、血管细胞黏附分子1(VCAM-1)和E-选择素1(ELAM-1)的表达。未刺激、血清饥饿的平滑肌细胞表达这些黏附分子的mRNA水平较低或无法检测到。IL-1β以浓度(1 fM - 1 nM)和时间(0.5 - 24小时)依赖性方式显著诱导ICAM-1和VCAM-1 mRNA的表达,但不诱导ELAM-1 mRNA的表达。IL-1β刺激后4小时,ICAM-1和VCAM-1 mRNA达到最大增加。IL-1β诱导的平滑肌细胞对单核细胞的黏附被单克隆抗人ICAM-1和抗人VCAM-1抗体部分抑制,但不被抗人ELAM-1抗体抑制。用抗人整合素β2抗体预处理单核细胞可显著降低单核细胞对IL-1β刺激的平滑肌细胞的黏附。这些结果表明,IL-1β是人类血管平滑肌细胞中ICAM-1和VCAM-1表达的有效诱导剂,并可能通过在病变中募集和保留单核细胞和中性粒细胞等炎症细胞在动脉粥样硬化的发病机制中发挥作用。